Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Genetron $126 million going-private transaction
We are separately advising Genetron and the special committee of its board on the transaction
Roivant Sciences registered direct offering and investment in Immunovant
We advised Roivant on the transactions
Inventiva $58 million at-the-market offering
The American depositary shares are listed on Nasdaq
HilleVax $115 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
RayzeBio $358 million IPO
The stock is listed on the Nasdaq Global Market
Natera $250 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
PracticeTek merger with Integrated Practice Solutions and related financing
We advised Lightyear Capital and PracticeTek on the transaction to form a leading U.S. retail healthcare solutions provider
Walgreens Boots Alliance registered variable prepaid forward transactions
The transactions cover up to 10,500,000 shares of AmerisourceBergen stock
Mallinckrodt prepackaged chapter 11 filing and restructuring support agreement
We are advising an ad hoc group of first-lien noteholders
Abcam $5.7 billion acquisition by Danaher
We advised financial advisers to Abcam on the transaction